Welcome to our dedicated page for Agronomics news (Ticker: AGNMF), a resource for investors and traders seeking the latest updates and insights on Agronomics stock.
Agronomics Limited (AGNMF) is a London-listed investment company focused on clean food and cellular agriculture, and its news flow reflects activity across a portfolio of more than 20 private companies in this emerging field. Company announcements cover new investments, follow-on funding, portfolio milestones and periodic updates on net asset value, giving readers insight into how Agronomics is deploying capital and how its holdings are progressing.
Recent news has highlighted additional investments in precision fermentation businesses, such as funding for All G Co Holdings Pty Limited, which develops human and bovine milk proteins like lactoferrin without the use of animals. Agronomics has also reported further equity investment in BlueNalu, Inc., a cell-cultivated seafood company working on products such as cultivated bluefin tuna toro for premium foodservice markets.
Updates on other portfolio companies include Liberation Bioindustries, which is building a commercial-scale precision fermentation facility to produce bio-based protein and other ingredients, Geltor, Inc., which has received an FDA “no questions” letter confirming GRAS status for its vegan collagen polypeptide PrimaColl, Clean Food Group Limited, which manufactures sustainable oils and fats through fermentation, and Onego Bio, whose precision-fermented egg protein Bioalbumen has also received an FDA GRAS “no questions” letter.
News items may also cover less favourable developments, such as the dissolution of Meatable B.V., and periodic net asset value calculations that summarise the impact of portfolio movements and foreign exchange changes on Agronomics’ balance sheet. For investors and observers interested in cellular agriculture and alternative proteins, the Agronomics news stream provides regular, company-sourced updates on financing rounds, regulatory progress and commercial partnerships across this specialised investment portfolio.
Agronomics (OTC:AGNMF) disclosed that Executive Chair Jim Mellon acquired a total of 3,308,995 ordinary shares between 6 and 12 March 2026 at prices ranging from 6.6p to 7.0p per share.
The purchases raise his combined interest to 165,775,997 shares (15.69% of voting rights). The notification was made under UK Market Abuse Regulation rules and is now public information.
Agronomics Limited (OTC:AGNMF) disclosed that Galloway Limited, an entity indirectly wholly owned by Executive Chair Jim Mellon, acquired a total of 990,000 ordinary shares between 23–25 February 2026 at prices of 6.63–6.65 pence per share.
After these purchases, Jim Mellon’s aggregate interest across closely associated entities is 161,891,217 ordinary shares, representing 15.32% of voting rights. The transaction notification complies with UK Market Abuse Regulation requirements.
Agronomics (OTC:AGNMF) reported unaudited interim results for the six months ending 31 December 2025, recording a net profit of £10,012,753 versus a prior-period loss. NAV per share rose to 13.78p (30 Jun 2025: 12.34p), up 11.7%, while share price closed at 6.2p, a 55% discount to NAV.
Net investment gains were £10.71m; invested assets carrying amount was £137.95m; cash and equivalents were £2.15m. Portfolio and post-period transactions included equity issues to SuperMeat and Blue Nalu, a full write-down of Meatable (£11.9m), and further investment in All G.
Agronomics (OTC:AGNMF) reported an unaudited Net Asset Value (NAV) per share of 13.78p at 31 December 2025, down 5.9% from 14.65p at 30 September 2025, with Net Assets of £140.0m and investments of £138.0m.
The quarter included a full write-off of Meatable (£11.9m), audited fair value movements across several portfolio holdings, issuance of new shares to Supermeat and Blue Nalu, and cash and deposit balances of £2.1m.
Agronomics (OTC:AGNMF) will invest AU$3.0m in All G via a Note Purchase Agreement as part of a minimum AU$10m funding round. Notes carry a 6% coupon, 24‑month maturity and convert to All G shares with a 20% discount if conversion occurs within 18 months or 30% after 18 months. Agronomics will satisfy the consideration by issuing 10,026,375 new ordinary shares at 14.65p per share. Post-transaction Agronomics' All G exposure will be ~£8.9m, ~4.99% of reported NAV (£147.8m). New shares expected admitted on 21 January 2026.
Agronomics (OTC:AGNMF) has subscribed for US$600,000 of Convertible Promissory Notes and purchased 1,012,229 Preferred Shares in BlueNalu for approximately US$6,000,000, satisfied by issuing 30,643,003 Agronomics ordinary shares at 14.65p each.
After the transactions and completion of BlueNalu's CPN round, Agronomics' stake in BlueNalu is expected to be 12.96% fully diluted; Agronomics will hold 2,519,609 Preferred Shares with a book value of ~US$15,540,000. CPNs convert on a qualifying financing (≥US$10m) with a 20% discount or valuation cap. Admission of the new Agronomics shares to AIM is expected on or around 7 January 2026.
Agronomics (OTC:AGNMF) announced on 19 December 2025 that its portfolio company Meatable will be dissolved and all operating activities terminated following a board and shareholder resolution.
The company cited funding shortfalls and other risks during 2025 that prevented continued operations. Agronomics has invested £7.9m in Meatable, previously carried at £11.9m, and will write that investment down to zero. The write-off represented approximately 8.10% of Agronomics' NAV as at 30 September 2025. The wind-down will follow statutory liquidation procedures.
Agronomics (OTC:AGNMF) announced that portfolio company Liberation Bioindustries closed the first tranche of its Series A1 equity round on 19 December 2025.
Liberation is constructing a 600,000‑liter commercial precision‑fermentation facility to produce protein and bio‑based ingredients. Agronomics converted its convertible loan notes into Series A1 shares, increasing its A1 shareholding from 6,834,147 to 16,538,437. Agronomics has invested US$27.0m to date; the investment is now carried at US$46.8m (c. £35m), a recorded uplift of US$2.5m. The position represents approximately 23% of Agronomics' net asset value as of 30 Sep 2025. New Agrarian Company will invest US$2.5m in the round.
Agronomics (AGNMF) reports that portfolio company Geltor received a US FDA "No Questions" letter confirming GRAS status for PrimaColl®, the first biodesigned vegan collagen polypeptide cleared for food use.
PrimaColl® is commercially scaled, designed to mimic avian Type 21 collagen, and positioned for both ingestible and topical markets; topical availability is global. Agronomics has invested £7.2 million in Geltor to date, with the holding currently carried at approximately £237,617 (~0.16% of Agronomics NAV of £145.3m as of 30 June 2025).
Agronomics (LSE:ANIC) announced that its portfolio company, Clean Food Group (CFG), has acquired the assets of Algal Omega 3 Ltd, gaining access to 1 million liters of fermentation capacity in Liverpool. The acquisition positions CFG as one of the world's largest manufacturers of yeast fermentation-derived sustainable oils and fats.
The 12-acre Liverpool facility includes R&D capabilities and has already demonstrated successful commercial-scale production with 2 tons of oil in a recent fermentation run. CFG recently received regulatory approval for its CLEAN Oil™ 25 product for cosmetic use in the UK, Europe, and US. The company aims to address a $20 billion market opportunity and plans a Series A funding round in H1 2026.
Agronomics' investment of £1.6 million in CFG is currently valued at £6.9 million, representing approximately 4.8% of Agronomics' last stated Net Asset Value as of June 30, 2025.